A/B testing is the gold standard of experimentation. It is meant to help companies make faster, better, data-driven decisions. But too often, it does the opposite. The meeting starts with optimism: a ...

Hydronuclear experiments, barred globally since the 1990s, may lie behind President Trump’s call last month for the United States to resume its testing of nuclear bombs. By William J. Broad President ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

President Trump's comments about restarting weapons tests are not likely to lead to mushroom-cloud explosions over the New Mexico desert or seismic shaking underground in Nevada, according to the ...

Washington — President Trump directed the Pentagon on Wednesday to resume testing of nuclear weapons "on an equal basis" with other countries' tests, possibly ending a decades-long U.S. pause that ...

"We've halted many years ago, but with others doing testing I think it's appropriate to do so," the president told reporters aboard Air Force One. Experts say that the resumption of testing would be a ...

President Trump said Wednesday that he has instructed the Defense Department to immediately begin testing U.S. nuclear weapons on an equal basis to China and Russia. “The United States has more ...

BUSAN, South Korea — President Donald Trump appeared to suggest the U.S. will resume testing nuclear weapons for the first time in three decades, saying it would be on an "equal basis" with Russia and ...

Oct 30 (Reuters) - U.S. President Donald Trump ordered the U.S. military on Thursday to immediately resume testing nuclear weapons after a gap of 33 years, minutes before beginning a meeting with ...

Official support for free-threaded Python, and free-threaded improvements Python’s free-threaded build promises true parallelism for threads in Python programs by removing the Global Interpreter Lock ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...